0001766784-24-000002.txt : 20241022 0001766784-24-000002.hdr.sgml : 20241022 20241022143229 ACCESSION NUMBER: 0001766784-24-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241022 DATE AS OF CHANGE: 20241022 EFFECTIVENESS DATE: 20241022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mediar Therapeutics, Inc. CENTRAL INDEX KEY: 0001766784 ORGANIZATION NAME: IRS NUMBER: 832874878 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-466474 FILM NUMBER: 241385781 BUSINESS ADDRESS: STREET 1: 20 OVERLAND STREET STREET 2: SUITE 520 CITY: BOSTON STATE: MA ZIP: 02215 BUSINESS PHONE: 617-936-0960 MAIL ADDRESS: STREET 1: 20 OVERLAND STREET STREET 2: SUITE 520 CITY: BOSTON STATE: MA ZIP: 02215 D/A 1 primary_doc.xml X0708 D/A LIVE 0001766784 Mediar Therapeutics, Inc. 20 OVERLAND STREET SUITE 520 BOSTON MA MASSACHUSETTS 02215 617-936-0960 DELAWARE None None Corporation true Rahul Ballal c/o Mediar Therapeutics, Inc. 20 Overland Street, Suite 520 Boston MA MASSACHUSETTS 02215 Executive Officer Director Cassidy Blundell c/o Mediar Therapeutics, Inc. 20 Overland Street, Suite 520 Boston MA MASSACHUSETTS 02215 Director Michael Baran c/o Mediar Therapeutics, Inc. 20 Overland Street, Suite 520 Boston MA MASSACHUSETTS 02215 Director Meredith Fisher c/o Mediar Therapeutics, Inc. 20 Overland Street, Suite 520 Boston MA MASSACHUSETTS 02215 Director Maina Bhaman c/o Mediar Therapeutics, Inc. 20 Overland Street, Suite 520 Boston MA MASSACHUSETTS 02215 Director Andreas Jurgeit c/o Mediar Therapeutics, Inc. 20 Overland Street, Suite 520 Boston MA MASSACHUSETTS 02215 Director Anja Konig c/o Mediar Therapeutics, Inc. 20 Overland Street, Suite 520 Boston MA MASSACHUSETTS 02215 Director Simon Sturge c/o Mediar Therapeutics, Inc. 20 Overland Street, Suite 520 Boston MA MASSACHUSETTS 02215 Director Biotechnology Decline to Disclose 06b true 0001766784-23-000002 2022-11-18 false true false 0 85034866 85034866 0 false 17 0 0 0 false Mediar Therapeutics, Inc. /s/ Rahul Ballal Rahul Ballal Chief Executive Officer 2024-10-22